| SARC 012 |
| Sarcoma |
|
A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II Study of AZD0530, a Selective Src Kinase Inhibitor, in Patients with Recurrent Osteosarcoma Localized to the Lung
|
Our Locations
Penn Oncology Hematology AssociatesFarm Journal Building
230 West Washington Square
Second Floor
Philadelphia, PA 19106
215-829-6088
Fax: 215-829-6104
www.pennoncology.com
Penn Oncology Hematology Associates at Radnor
250 King of Prussia Road
Suite 1B
Radnor, PA 19087
610-902-5950
Fax: 610-902-5959
Joan Karnell Cancer Center at Pennsylvania Hospital
Farm Journal Building
230 West Washington Square
First Floor
Philadelphia, PA 19106
215-829-6466
www.pennhealth.com/karnell
Working together with...
